Oxford Immunotec Global
OXFD
OXFD was delisted on the 5th of March, 2021.
71 hedge funds and large institutions have $280M invested in Oxford Immunotec Global in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
42% more capital inflows, than outflows
Capital inflows: $23.3M | Capital outflows: $16.4M
9% more funds holding
Funds holding: 65 → 71 (+6)
1.97% more ownership
Funds ownership: 90.17% → 92.14% (+2%)
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$4.75M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.92M |
| 3 |
Tocqueville Asset Management
New York
|
+$2.75M |
| 4 |
Water Island Capital
New York
|
+$1.99M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deerfield Management
New York
|
-$2.88M |
| 2 |
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.8M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1.7M |
| 4 |
Morgan Stanley
New York
|
-$1.39M |
| 5 |
JP Morgan Chase
New York
|
-$1.22M |
OXFD Hedge Fund Activity: Q3 2020 in Review
71 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global (OXFD) for Q3 2020, worth a combined $280M — down 8% from $304M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new OXFD positions and 5 closed out — a net gain of 6 holders — while 22 added to existing stakes and 24 trimmed.
The largest buyer was Endurant Capital Management, adding an estimated $4.75M. The largest seller was Deerfield Management, cutting an estimated $2.88M.
- 71 institutional investors held Oxford Immunotec Global (OXFD) as of Q3 2020, up from 65 in Q2 2020.
- Funds reported $280M of Oxford Immunotec Global stock for Q3 2020, down 8% quarter-over-quarter.
- 11 funds opened new Oxford Immunotec Global positions in Q3 2020 and 5 closed out, a net change of +6 holders.
- The largest Oxford Immunotec Global buyer in Q3 2020 was Endurant Capital Management, an estimated $4.75M added.
- The largest Oxford Immunotec Global seller in Q3 2020 was Deerfield Management, an estimated $2.88M sold.
Based on aggregated 13F filings for Q3 2020.